Single-Use Assemblies Market Size, Share, Growth Analysis, By Product(Bag Assemblies, 2D bag assemblies, 3D bags assemblies, Filtration Assemblies), By Application(Filtration, Cell Culture & Mixing, Storage, Sampling), By Solution(Customized Solutions, and Standard Solutions), By Region - Industry Forecast 2024-2031

Global Single-Use Assemblies Market size was valued at USD 2.7 billion in 2022 and is poised to grow from USD 3.21 billion in 2023 to USD 12.73 billion by 2031, growing at a CAGR of 18.80% during the forecast period (2024-2031).

Single-use assemblies encompass pre-assembled plastic fluid pathways and self-contained products, constructed by combining various standard components, often ready for immediate use and gamma irradiated to ensure sterility. Commonly employed components encompass sampling bottles, filters, tubing, check valves, clamps, sterile connectors, fittings, and seals. The burgeoning biologics market, coupled with continuous technological strides in bioprocessing, amplified biopharmaceutical Research and Development (R&D), and the extensive adoption of single-use assemblies by diverse Contract Manufacturing Organizations (CMOs), are poised to propel industry expansion during the projected period.

Nonetheless, regulatory considerations linked to leachable, extractables, waste management, and the availability of multi-use systems might temper the penetration of single-use assemblies. The advent of COVID-19 has further accelerated the escalating demand for such assemblies, as disposable technology facilitates swift production and development of therapies and vaccines, enhancing precision and efficiency. A pertinent example is Entegris, Inc.'s Aramus single-use bag assembly, utilized to store COVID-19 vaccines requiring ultra-low temperatures for preservation.

The upsurge in cancer prevalence and infectious diseases is fueling the production of novel biologics for diagnosis and treatment. A rise in cancer cases and infectious diseases like lower respiratory infections and HIV, attributed to factors such as climate shifts and urbanization, augments the industry's prospects. Innovative vaccine developments, exemplified by Moderna's mRNA-based HIV vaccine clinical trial, spotlight cutting-edge technologies' role in the biologics arena. Collaborative endeavors to combat emerging infectious diseases with pandemic potential further underscore the drive towards novel vaccine alternatives.

US Single-Use Assemblies Market is poised to grow at a sustainable CAGR for the next forecast year.